MORGAN RYALS: Open Payments
NPI 1295322311 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,077 in 55 payments from 14 companies in 2025. Trend: 2023 $1,176 · 2024 $851 · 2025 $1,077
Food & beverage: $1,077
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $179 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $163 |
| Ardelyx, Inc. | 9 | $156 |
| Madrigal Pharmaceuticals | 4 | $138 |
| GENZYME CORPORATION | 4 | $122 |
| Janssen Biotech, Inc. | 6 | $115 |
| Ipsen Biopharmaceuticals, Inc | 2 | $43 |
| Novo Nordisk Inc | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
Products named: IBSRELA, DUPIXENT, REZDIFFRA, RINVOQ, TREMFYA, XIFAXAN, RELISTOR, IQIRVO.
Industry payments across AL — which companies pay providers there.
